Table 2 Cox regression analysis of prognostic factors for progression free interval in thyroid cancer
Characteristics | Univariate analysis | Â | Multivariate analysis | ||
|---|---|---|---|---|---|
Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | ||
Age (≤ 45 vs. >45) | 1.618 (0.935–2.869) | 0.085 |  |  |  |
Gender (Female vs. Male) | 1.541 (0.870–2.731) | 0.138 |  |  |  |
Histological type (Classical vs. Follicular &Tall Cell& Other) | 0.986 (0.534–1.822) | 0.965 |  |  |  |
Residual tumor (R0 vs. R1&R2) | 1.787 (0.862–3.703) | 0.118 |  |  |  |
Primary neoplasm focus type (Multifocal vs. Unifocal) | 0.956 (0.549–1.663) | 0.873 |  |  |  |
Thyroid gland disorder history (Normal vs. Nodular Hyperplasia & Lymphocytic Thyroiditis & Other) | 0.963 (0.518–1.788) | 0.904 |  |  |  |
BTNL9 (high vs. low) | 2.373 (1.302–4.326) | 0.005 |  | 1.931 (1.042–3.580) | 0.037 |
Pathologic stage (StageI & StageII vs. StageIII & StageIV) | 2.638 (1.528–4.555) | < 0.001 |  | 2.015 (1.082–3.751) | 0.027 |
Extrathyroidal extension (No vs. Yes) | 2.014 (1.162–3.490) | 0.013 |  | 1.279 (0.687–2.381) | 0.437 |